SODIUM SULFACETAMIDE 10% AND SULFUR 5% LOTION | Sodium Sulfacetamide and Sulfur
Each mL of Sodium Sulfacetamide 10% and Sulfur 5% Lotion as dispensed contains 100 mg of sodium sulfacetamide and 50 mg of sulfur in a tinted lotion of 2-bromo-2-nitropropane-1,3-diol, butylparaben, colloidal activated attapulgite, diethanolamine, hydroxyethyl cellulose, iron oxides, lauramide DEA, methylparaben, polyethylene glycol 400 monolaurate, propylene glycol, purified water, simethicone emulsion, sodium chloride, sodium metabisulfite, sodium polynaphthalenesulfonate, talc, titanium dioxide, xanthan gum, and zinc oxide. Color Tinter contains an additional inactive ingredient, polyethylene glycol 400.
Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N’-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate.
The structural formula is:
The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours.
The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.
Sodium Sulfacetamide 10% and Sulfur 5% Lotion is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Sodium Sulfacetamide 10% and Sulfur 5% Lotion is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur, or any other component of this preparation. This drug is not to be used by patients with kidney disease.
Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.
FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children.
Keep bottle tightly closed.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.
Long-term studies in animals have not been performed to evaluate carcinogenic potential.
Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% and Sulfur 5% Lotion. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. This drug should be given to a pregnant woman only if clearly needed.
It is not known whether sodium sulfacetamide is excreted in human milk following topical use of Sodium Sulfacetamide 10% and Sulfur 5% Lotion. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when this drug is administered to a nursing woman.
Safety and effectiveness in pediatric patients under the age of 12 have not been established.
Although rare, sodium sulfacetamide may cause local irritation.
Shake well before using. Apply a thin film to affected areas with light massaging to blend in each application 1 to 3 times daily, or as directed by a physician. Each package contains a color tinter which enables the patient to alter the basic shade of the lotion so that it matches the skin color exactly.
(Important to the Pharmacist: At the time of dispensing, add contents of sodium sulfacetamide vial* to the bottle. Shake well and/or stir with a glass rod to insure uniform dispersion. Place expiration date of four (4) months on bottle label.)
*Sodium Sulfacetamide vial contains 2.1 g of sodium sulfacetamide.
Sodium Sulfacetamide 10% and Sulfur 5% Lotion is available
as follows: 25 g bottle (NDC 45802-978-01)
Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
STIEFEL LABORATORIES, INC.,
CORAL GABLES, FL 33134
ALLEGAN, MI 49010
Sodium Sulfacetamide 10% and Sulfur 5% Lotion
Description: Vial contains sodium sulfacetamide. Prior to dispensing, add contents of vial to lotion. The completed formulation then contains sodium sulfacetamide 10% and precipitated sulfur 5%.
Sodium Sulfacetamide 10% and Sulfur 5% Lotion
(Supply separately to patient)
Manufactured by Stiefel Lab., Inc.
Coral Gables, FL 33134
Distributed by Perrigo®
Allegan, MI 49010
Perrigo New York Inc
Drugs and Medications
SODIUM SULFACETAMIDE 10% AND SULFUR 5% LOTION
Sumaxin(sodium sulfacetamide 9% and sulfur 4%)Wash
Sumaxin (sodium sulfacetamide 8% and sulfur 4%) TS
10% Sodium Sulfacetamide and Sulfur 5% Aqueous Gel (in a Urea vehicle) Rx only
sumaxin (sodium sulfacetamide 10% & sulfur 4%) Cleansing Pads
The purpose of this study is to determine the level of sulfur amino acids in the diet that is needed to maintaining glutathione antioxidant status. This information could prove very usefu...
to assess the effect of Heliox with Noninvasive positive pressure ventilation to decrease dyspnea and improve physiologic and respiratory measures in patients with a previous exposure to S...
To compare, through a randomized, multicenter surgical trial, the postoperative tamponade effectiveness of intraocular silicone oil with that of an intraocular long-acting gas (initially s...
to assess the effectiveness of helium:oxygen mixture adjunct with non-invasive ventilation in sulfur mustard exposed patients with acute decompensation
The loss of sodium during infancy causes long term changes in sodium intake. Human research shows that the loss of maternal sodium during pregnancy and neonatal after birth causes an incre...
A mild and efficient synthesis of sulfur-sulfur bond formation from thioformanilides with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) is described. Functionality on the aromatic ring plays a key role i...
The sodium-sulfur (NAS) battery is a candidate for energy storage and load leveling in power systems, by using the reversible reduction of elemental sulfur by sodium metal to give a liquid mixture of...
Three sodium thiosulfonate salts, NaMeS(2)O(2)·H(2)O, NaPhS(2)O(2) and NaMeC(6)H(4)S(2)O(2) have been prepared by the direct reaction of the sodium sulfinate salts with elemental sulfur, a clean, ben...
Porous Pt nanostructure decorated sulfur microparticles (Pt@S) are fabricated using sulfur as the template. The Pt@S electrode shows a higher volumetric specific capacity of 520 mA h cm(-3) and improv...
The composition of sulfur isotopes in sedimentary sulfides and sulfates traces the sulfur cycle throughout Earth's history. In particular, depletions of sulfur-34 ((34)S) in sulfide relative to sulfat...